Autism Spectrum Disorder News – Stem Cells Treatment

There are numerous different symptoms amongst autistic children, which is why the term “autism spectrum disorder” (ASD) classifies the whole range of conditions. This characterizes all of these neurodevelopmental disabilities, such as difficulties with social interaction, including any form of communication. These problems usually manifest in early childhood. Parents might notice that a child doesn’t participate in social situations, and doesn’t respond when called by the name. Playing, laughing, talking and keeping eye contact might all be decreased or missing activities in a child suffering from autism spectrum disorder. Anxiety and mood swings are common. Digestive and metabolic problems may be present in some cases.

In Order to Be Happy, an Autistic Person Shoud Have:

A feeling that their life is well planned.
A well-adapted communication system.
Self-care skills.
Ability to study and work.
Leisure skills.
Communication skills (and to be glad of the communication).

The first step toward happiness in an autistic child is to establish good health and maintain it. Happiness in autistic children is benefitted by reducing anxiety through planning, limiting the unexpected by giving the child an itinerary that discloses all obligations, events, activities, when they occur and end, including leisure time and bedtime. Simply having a plan has been shown to improve behavior in new or unfamiliar places.

Happiness is further promoted by establishing healthy stimulation through learning, working toward goals and developing lasting, enriching relationships. These steps help prepare autistic patients to develop skills that will help them achieve a happy adult life with communication, self-care, educational and professional capabilities.

Stem Cell Treatment for Autism in Europe

Autism spectrum disorder affects more than 21 million people around the world. There is no cure and up until recently, improvements in those suffering from ASD were often mild. Unlike the rest of the medications and educational interventions used when treating autism spectrum disorder, stem cell treatment offers a completely new, revolutionary approach. This unique therapy does not only treat the symptoms but the very core of the problem. Stem cells come from a person’s own body and they are a natural part of its repair system. Because of this, they have the ability to recognize the body’s own needs and also to find problematic areas and improve it. Due to the treatment, brain cells are rejuvenated, renewed and the symptoms are reversed.

Treatment with stem cells is completely safe, easy, painless, non-traumatic, and the procedure takes only a couple of hours. After the therapy, symptoms of a person suffering from ASD are slowly improving over the next several months. Overall health and quality of life reach a significantly higher level.

Stem Cell Therapy in Autism

Swiss Medica is a clinic specialized in the treatment of autism spectrum disorder located in Europe and using the newest methods of treatment with stem cells. Following new researches in the field of neurodegenerative diseases, current autism treatment in children shows very good results. In addition to stem cell therapy, in process of therapy may be included neurologist, psychologist, psychiatrist in order to develop the educational and social program, depending on the patient.

In addition to modern equipment, we offer a special kind of privacy for each patient and full commitment of staff. Surrounded by greenery and a large courtyard with flowers and ornamental plants, it makes you feel comfortable during your stay. In addition to accommodating an autistic patient, their caregivers may also stay in the clinic.

Swiss Medica clinics that provide treatment for autism are located in Belgrade and Moscow which are well conventionally connected near main European cities, such as Istanbul, Rome, Paris, Berlin, London, Vienna, Barcelona, etc. Due to the good geographical position and good flight connections with other parts of the world, we are available to patients from the Middle East and the western part of Asia.